Where to Buy Semaglutide in 2026: Verified US Provider List

Semaglutide is sold in the United States under three brand names — Wegovy (FDA-approved for chronic weight management)^[1], Ozempic (FDA-approved for type 2 diabetes)^[2], and Rybelsus (oral tablet for type 2 diabetes). It is also still legally available as a 503A compounded injectable through telehealth platforms, even though the FDA declared the semaglutide shortage resolved in early 2025^[5]. This article walks through every legitimate US channel a patient can use to buy semaglutide in 2026, with verified pricing from FDA labels, the NovoCare patient site, and our live 80-provider compounded pricing dataset.

The four legal ways to buy semaglutide in 2026

There are exactly four legitimate channels. Anything outside these — research peptides, gray-market vials shipped from overseas, sellers operating without a prescription — is either illegal, unsafe, or both. Stick to one of the following.

1. Brand Wegovy or Ozempic via retail pharmacy with insurance^[1]

• What it is: A standard prescription for brand-name Wegovy or Ozempic, filled at a normal retail pharmacy (CVS, Walgreens, Walmart, Costco, grocery store pharmacies, Amazon Pharmacy) and run through your commercial insurance.
• How to get it: See your PCP or a telehealth clinician. Wegovy requires documentation of BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia). Ozempic requires a documented type 2 diabetes diagnosis.
• Cash price without insurance: Roughly $1,000-$1,400/month at the major retail pharmacies for either Wegovy or Ozempic.
• Insured copay: Highly variable. With a covered formulary plan plus the Novo Nordisk savings card, commercially insured patients can sometimes pay as little as $0-$25/month. Without coverage, the savings card alone caps the price at a higher cash-equivalent tier.

2. NovoCare Pharmacy direct-pay (the manufacturer cash channel)^[3]

• What it is: Novo Nordisk's own self-pay pharmacy channel for cash-paying patients without insurance coverage for Wegovy. Launched in March 2025 alongside the resolution of the semaglutide shortage.
• How to get it: Get a Wegovy prescription from any licensed US prescriber, then fill it through NovoCare Pharmacy directly. You bring your own prescription; NovoCare dispenses and ships.
• Cash price (current Take a Wegovy Step promotion, effective November 17, 2025 through June 30, 2026): new self-pay patients pay $199/month for the first two fills of the 0.25 mg and 0.5 mg starter doses, then $349/month for all doses thereafter under the promotional tier. The non-promotional baseline is $499/month for all Wegovy doses, including the higher 1.7 mg and 2.4 mg maintenance doses that are normally the most expensive at retail pharmacies. Even the $499 baseline is roughly a 65% discount versus retail cash pay. Promotion is subject to change — verify current pricing directly at NovoCare before enrolling.
• Eligibility: Cash-paying US patients only. Patients with insurance that covers Wegovy are routed to the standard pharmacy benefit instead.
• Shipping: Direct to patient, all 50 states.

3. Compounded semaglutide via 503A telehealth pharmacy^[4]

• What it is: A compounded preparation of semaglutide (typically as semaglutide sodium or semaglutide acetate, in a multi-dose vial) prepared by a state-licensed 503A compounding pharmacy on a patient-specific prescription. This is the channel that dominated the telehealth market during the 2022-2025 semaglutide shortage.
• Legal status in 2026: The FDA declared the semaglutide injection shortage resolved on February 21, 2025^[5]. After resolution, 503B outsourcing facilities can no longer mass-compound semaglutide. 503A pharmacies can still compound semaglutide for an individual patient when a prescriber documents a clinical need (e.g., a different dose, an allergy to an excipient, a non-commercial formulation). Most telehealth platforms continue to operate through this 503A pathway.
• Cash price: Typically $99-$249/month across the 80+ telehealth providers in our dataset, depending on the provider, the dose, and any first-month promotional pricing. Our GLP-1 Compounded Pricing Index tracks the median, 10th percentile, and 90th percentile prices live as our dataset updates.
• How to verify a provider: Look for PCAB accreditation, state board of pharmacy licensure in your state, and a real US-based clinician consult. See our PCAB accreditation investigation for the full vetting framework.
• What to avoid: Any seller offering semaglutide without a prescription, any product shipped from outside the US, anything sold as "research peptide" or "not for human use," and any pharmacy that cannot show you a state license.

4. The insurance prior-authorization path

• What it is: The traditional pharmacy benefit path, where your commercial insurance covers Wegovy on formulary subject to prior authorization (PA) and step therapy requirements.
• How it works: Your prescriber submits a PA documenting BMI, comorbidities, and prior weight-loss attempts. If approved, you pay a standard tier copay (often $25-$100/month depending on the plan).
• Reality check: Most commercial plans now cover Wegovy on formulary, but coverage for obesity medications is still inconsistent. Medicare historically excluded weight-loss drugs entirely; in March 2024 CMS allowed Part D coverage of Wegovy for patients with established cardiovascular disease who are also overweight or obese. State Medicaid coverage varies. Our GLP-1 insurance coverage research breaks down which plans cover what.

Which channel is cheapest?

The honest answer depends on your insurance status and which form of semaglutide you are willing to take. Here is the rough hierarchy in 2026:

1. Insurance + Wegovy savings card — often $0-$25/month if your plan covers Wegovy and you qualify for the manufacturer copay card. This is the cheapest path when it works.
2. Compounded semaglutide via 503A telehealth — $99-$249/month with no insurance required. The cheapest path for cash-pay patients, but you are getting a compounded preparation, not the brand-name FDA-approved product.
3. NovoCare Pharmacy direct-pay — currently $199/month for the first two starter-dose fills and $349/month thereafter for new self-pay patients under the Take a Wegovy Step promotion (effective 11/17/2025 through 6/30/2026); the non-promotional baseline is $499/month for all doses. The cheapest path to brand-name semaglutide for cash-pay patients. Verify current pricing directly at NovoCare.
4. Retail pharmacy cash pay — $1,000-$1,400/ month. Generally the most expensive option and rarely the right choice when NovoCare exists.

For a side-by-side cost comparison across the entire provider universe, see our cheapest semaglutide providers listicle and the cheapest compounded semaglutide research. For the full ranked directory of every telehealth platform offering semaglutide, see best semaglutide providers.

How the dispensing chain actually works

Semaglutide reaches a US patient through one of three distinct supply chains, and it's worth understanding which one you're using:

• Brand Wegovy or Ozempic — manufactured by Novo Nordisk, distributed through standard pharmaceutical wholesalers, dispensed by retail and mail-order pharmacies. NovoCare Pharmacy is Novo Nordisk's own direct-to-patient channel using the same brand-name drug.
• Compounded semaglutide — semaglutide API (active pharmaceutical ingredient) sourced from FDA- registered API suppliers, prepared into a multi-dose vial by a state-licensed 503A compounding pharmacy on a patient-specific prescription, dispensed directly to the patient. The clinician consult and the program wrap are provided by the telehealth platform on top of the pharmacy.
• Imported or research-grade peptides — neither legal nor safe. The FDA has issued multiple warnings about the unverified identity, purity, and sterility of semaglutide products sourced outside the legitimate compounding pathway^[4]. Avoid.

Where NOT to buy semaglutide

• Anywhere selling semaglutide without a US prescription
• Any seller shipping from China, India, or Eastern Europe
• Any product labeled "for research use only" or "not for human consumption"
• Any peptide vendor not operating as a state-licensed pharmacy
• Any platform that does not require a real clinician consult (a quick form does not count as a medical visit)
• Any "wellness" or "biohacking" site selling semaglutide as a supplement

How to actually start

1. Check your insurance. Call the member services number on your insurance card and ask specifically: "Is Wegovy on formulary? What is the prior authorization requirement? What is my copay?" If your plan covers it, this is almost always the cheapest path.
2. If insurance doesn't cover it, decide whether you want brand-name semaglutide or a compounded preparation. Brand-name via NovoCare currently runs $199/month for the first two starter-dose fills and $349/month thereafter under the Take a Wegovy Step promotion through 6/30/2026, with a $499/month non-promotional baseline for all doses. Compounded via 503A telehealth is $99-$249/month.
3. Get a clinician consult. See our how to get a GLP-1 prescription guide for the full eligibility framework and the step-by-step path through PCP, telehealth, and obesity medicine specialists.
4. Verify the pharmacy. If you go the compounded route, confirm PCAB accreditation and state board of pharmacy licensure before you pay anything. The telehealth platform should be transparent about which pharmacy fills the prescription.

Related research and tools

• Best semaglutide providers — full ranked directory of every US telehealth platform offering semaglutide
• Cheapest semaglutide providers — sorted by lowest monthly cash price
• GLP-1 Compounded Pricing Index 2026 — live median, p10, p90 pricing across 80+ providers
• Cheapest compounded semaglutide research — methodology behind the cheapest-tier rankings
• Compounded GLP-1 price movement (12 months) — how pricing has shifted post-shortage-resolution
• How to get a GLP-1 prescription in 2026 — eligibility, consult paths, and the four-channel buyer funnel
• GLP-1 insurance coverage: Medicare, Medicaid, commercial — what each plan type actually covers
• PCAB accreditation investigation — how to vet a compounding pharmacy

Frequently asked questions

Is it legal to buy compounded semaglutide in 2026?

Yes, with limits. After the FDA declared the semaglutide shortage resolved on February 21, 2025^[5], 503B outsourcing facilities can no longer mass-compound semaglutide. 503A pharmacies can still compound semaglutide for an individual patient when a prescriber documents a clinical need (such as an allergy to an excipient or a dose not commercially available). Most telehealth platforms still operate through this 503A pathway.

What is the cheapest legal way to get semaglutide?

For commercially insured patients, the Wegovy savings card combined with insurance coverage is usually the cheapest path. Without insurance, the current NovoCare Pharmacy Take a Wegovy Step promotion (effective November 17, 2025 through June 30, 2026) offers new self-pay patients $199/month for the first two fills of the 0.25 mg and 0.5 mg starter doses and $349/month thereafter; the non-promotional baseline is $499/month for all Wegovy doses^[3]. 503A compounded semaglutide via telehealth ranges from roughly $99 to $249/month depending on the provider and dose. Promotion subject to change — verify current pricing directly at NovoCare.

Can I buy Ozempic for weight loss?

Ozempic is FDA-approved for type 2 diabetes, not for weight loss^[2]. A clinician can prescribe it off-label for weight loss, but most commercial insurers will not cover Ozempic without a diabetes diagnosis. Wegovy is the FDA-approved semaglutide product for chronic weight management.

How much does Wegovy cost without insurance in 2026?

List price at retail pharmacies is roughly $1,350/month. Through Novo Nordisk's NovoCare Pharmacy direct-pay program, the current Take a Wegovy Step promotion (effective November 17, 2025 through June 30, 2026) offers new self-pay patients $199/month for the first two fills of the 0.25 mg and 0.5 mg starter doses and $349/month for all doses thereafter. The non-promotional baseline is $499/month for all Wegovy doses^[3]. Compounded semaglutide via telehealth is typically $99-$249/month but is not the brand-name product. Promotion subject to change — verify current pricing directly at NovoCare.

Does Medicare cover semaglutide?

Medicare Part D covers Ozempic for type 2 diabetes. Wegovy for weight loss has historically not been covered by Medicare for obesity alone, though coverage was expanded in March 2024 for patients with established cardiovascular disease and overweight or obesity. Medicaid coverage varies by state.

How do I know if a compounded semaglutide pharmacy is legitimate?

Look for PCAB accreditation through the Accreditation Commission for Health Care, verify the pharmacy is licensed in your state through your state board of pharmacy, and confirm it operates as a 503A compounding pharmacy with a valid patient-specific prescription^[6]. Avoid any seller offering semaglutide without a prescription or shipping from outside the US.

Important disclaimer. This article is educational and does not constitute medical advice. Pricing is verified directly from FDA labels, the NovoCare patient site, and our 80-provider compounded pricing dataset on the publication date. Pricing and availability change frequently — verify directly with the provider before signing up. This is a YMYL article about a real prescription drug; clinical decisions should always involve your prescribing clinician. Weight Loss Rankings has no financial relationship with Novo Nordisk or any of the providers referenced.